Neuroendocrine Carcinomas with Atypical Proliferation Index and Clinical Behavior: A Systematic Review.

Tiziana FeolaRoberta CentelloFranz Sesti Giulia PulianiMonica VerricoValentina Di VitoCira Rosaria Tiziana di GioiaOreste BagniAndrea LenziAndrea M IsidoriElisa GiannettaAntongiulio Faggiano

Published in: Cancers (2021)

NECs are heterogeneous tumors. The subgroup with a Ki67 LI < 55% has a better prognosis and should be treated and monitored differently from NECs with a Ki67 LI ≥ 55%.

Keyphrases

ion batteries
neoadjuvant chemotherapy
signaling pathway
solid state
high grade
randomized controlled trial
phase iii
squamous cell carcinoma